Sector
PharmaceuticalsOpen
₹94Prev. Close
₹94.93Turnover(Lac.)
₹4.74Day's High
₹95Day's Low
₹93.0252 Week's High
₹15552 Week's Low
₹79Book Value
₹57.56Face Value
₹10Mkt Cap (₹ Cr.)
71.1P/E
16.22EPS
5.82Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 7.53 | 7.53 | 7.53 | 7.53 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 31.44 | 25.89 | 22.1 | 16.86 |
Net Worth | 38.97 | 33.42 | 29.63 | 24.39 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 161.1 | 122.67 | 95.69 | 64.44 |
yoy growth (%) | 31.33 | 28.18 | 48.48 | -14.74 |
Raw materials | -130.45 | -96.58 | -76.67 | -49.27 |
As % of sales | 80.97 | 78.73 | 80.11 | 76.45 |
Employee costs | -4.95 | -3.94 | -3.44 | -2.66 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 7.02 | 5.7 | 2.28 | 1.31 |
Depreciation | -1.69 | -1.22 | -1.16 | -0.98 |
Tax paid | -1.77 | -1.57 | -0.28 | -0.48 |
Working capital | -5.22 | 7.07 | 3.56 | 1.95 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 31.33 | 28.18 | 48.48 | -14.74 |
Op profit growth | 14.88 | 62.82 | 49.37 | -22.62 |
EBIT growth | 9.49 | 73.34 | 39.35 | -28.47 |
Net profit growth | 27.06 | 106.32 | 141.23 | -54.15 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Mukund Kakani
Non-Exec. & Independent Dir.
S A Hussain
Whole Time Director & CFO
Mohit Jaju
Non-Exec. & Independent Dir.
Vimala B Madon
Chairman (Non-Executive)
Ghanshyam Jaju
Non Executive Director
Mahindra Uday Bhalerao
Independent Director
Dinesh Udpa
Company Sec. & Compli. Officer
Venkatesh Achanta
Mayfair 1-8-303-34,
Sardar Patel Road,
Andhra Pradesh - 500003
Tel: 91-40-27849700/27844557
Website: http://www.godavaridrugs.com
Email: info@godavaridrugs.com
214 RaghavaRatna Tow,
Chiragali Lane, Abids,
Hyderabad 500001
Tel: 91-040-23202465/2320
Website: www.cilsecurities.com
Email: cilsec@hotmail.com
Summary
Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India.. S...
Read More
Reports by Godavari Drugs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.